Del Giudice Matthew Paul
SEC insider (Form 3/4/5 filer). CIK 0002016630. Director at Telomir Pharmaceuticals, Inc. (TELO) and 1 other issuer. 5 reported Form 4/5 transactions since Sep 2024; latest on Jun 12, 2026. Located in MIAMI, FL.
Companies Del Giudice Matthew Paul has filed insider reports for
- Telomir Pharmaceuticals, Inc. (TELO): Director
- MIRA PHARMACEUTICALS, INC. (MIRA): Director
Del Giudice Matthew Paul
CIK: 0002016630
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jun 12, 2026MIRA
MIRA PHARMACEUTICALS, INC.
AwardDirectStock Options (right to buy)
50K shares- - May 21, 2026TELO
Telomir Pharmaceuticals, Inc.
AwardDirectIncentive Stock Options (right to buy)
25K shares- - May 21, 2026TELO
Telomir Pharmaceuticals, Inc.
DispositionDirectIncentive Stock Options (right to buy)
25K shares- - Apr 16, 2026TELO
Telomir Pharmaceuticals, Inc.
AwardDirectNon-Qualified Stock Options (right to buy)
50K shares- - Dec 9, 2024MIRA
MIRA PHARMACEUTICALS, INC.
AwardDirectStock Options (right to buy)
25K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 12, 2026 |  MIRA MIRA PHARMACEUTICALS, INC. | Award Stock Options (right to buy) | 50,000 | - | - | Direct |
| May 21, 2026 |  TELO Telomir Pharmaceuticals, Inc. | Award Incentive Stock Options (right to buy) | 25,000 | - | - | Direct |
| May 21, 2026 | TELO Telomir Pharmaceuticals, Inc. | Disposition Incentive Stock Options (right to buy) | 25,000 | - | - | Direct |
| Apr 16, 2026 | TELO Telomir Pharmaceuticals, Inc. | Award Non-Qualified Stock Options (right to buy) | 50,000 | - | - | Direct |
| Dec 9, 2024 | MIRA MIRA PHARMACEUTICALS, INC. | Award Stock Options (right to buy) | 25,000 | - | - | Direct |
1-5 of 5 transactions